- Home
- IMCC vs AIMD Comparison
IMCC vs AIMD Comparison
Compare IMCC & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- AIMD
- Stock Information
- Founded
- IMCC 1980
- AIMD 1984
- Country
- IMCC Israel
- AIMD United States
- Employees
- IMCC N/A
- AIMD N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- AIMD Health Care
- Exchange
- IMCC Nasdaq
- AIMD Nasdaq
- Market Cap
- IMCC 7.5M
- AIMD 8.2M
- IPO Year
- IMCC N/A
- AIMD N/A
- Fundamental
- Price
- IMCC $2.19
- AIMD $0.63
- Analyst Decision
- IMCC
- AIMD
- Analyst Count
- IMCC 0
- AIMD 0
- Target Price
- IMCC N/A
- AIMD N/A
- AVG Volume (30 Days)
- IMCC 19.9K
- AIMD 1.4M
- Earning Date
- IMCC 11-14-2024
- AIMD 03-07-2025
- Dividend Yield
- IMCC N/A
- AIMD N/A
- EPS Growth
- IMCC N/A
- AIMD N/A
- EPS
- IMCC N/A
- AIMD N/A
- Revenue
- IMCC $38,042,859.00
- AIMD $40,633.00
- Revenue This Year
- IMCC $22.59
- AIMD N/A
- Revenue Next Year
- IMCC $32.86
- AIMD N/A
- P/E Ratio
- IMCC N/A
- AIMD N/A
- Revenue Growth
- IMCC N/A
- AIMD N/A
- 52 Week Low
- IMCC $1.13
- AIMD $0.40
- 52 Week High
- IMCC $8.10
- AIMD $3.10
- Technical
- Relative Strength Index (RSI)
- IMCC 43.17
- AIMD 54.51
- Support Level
- IMCC $2.11
- AIMD $0.61
- Resistance Level
- IMCC $2.70
- AIMD $0.77
- Average True Range (ATR)
- IMCC 0.30
- AIMD 0.12
- MACD
- IMCC -0.01
- AIMD 0.01
- Stochastic Oscillator
- IMCC 11.02
- AIMD 34.07
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.